Lion Point Life Sciences Partners, LP — Form D/A

Lion Point Life Sciences Partners, LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2023-06-15. $20.8M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2023-06-15
• Form: D/A
• Accession: 0001315863-23-000620
• Industry: Pooled Investment Fund
• Exemptions: 06b, 3C, 3C.7
• Amount sold: $20.8M
• Investors: 3
• Date of first sale: 2022-07-01
• Security types: equity, fund interests
• SEC file number: 021-452155

Issuer

• Name: Lion Point Life Sciences Partners, LP
• CIK: 0001937572
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Address: 250 WEST 55TH STREET, NEW YORK, NY, 10019
• Phone: 212.356.6200

Officers, directors & promoters (1)

Other filings by this issuer (1)

More

• CIK 1937572 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search